v3.26.1
CONSOLIDATED BALANCE SHEETS - USD ($)
Sep. 30, 2025
Sep. 30, 2024
Current Assets:    
Cash and restricted cash $ 390,706 $ 317,323
Accounts receivable, net 1,650,231 11,790,391
Inventories, net 3,640,861 3,329,344
Advances to suppliers, net 21,446,203 26,488,494
Other receivable 0 18,709,318
Loan to a third party 4,749,572 0
Acquisition reversal receivable 33,151,699 0
Prepaid expenses and other current assets 739,319 863,690
Total current assets 65,768,591 61,498,560
Non-Current Assets:    
Biological assets, net 0 28,522,903
Long-term investments 40,604,689 0
Land use right, net 0 6,205,309
Property and equipment, net 879,246 2,012,955
Right-of-use assets 61,885 122,779
Total non-current assets 41,545,820 36,863,946
Total Assets 107,314,411 98,362,506
Current Liabilities:    
Accounts payable 145,435 535,221
Convertible notes 3,432,353 0
Due to related parties 0 611,327
Remaining acquisition consideration payable 715,348 0
Taxes payable 2,717 108
Accrued expenses and other current liabilities 434,925 303,433
Total current liabilities 4,730,778 1,450,089
Non-Current Liability:    
Due to related parties 611,327 0
Total non-current liability 611,327 0
Total liabilities 5,342,105 1,450,089
Shareholders' Equity:    
Additional paid-in capital 8,865,199 8,865,199
Statutory reserves 11,404 14,990
Accumulated deficits (27,879,848) (16,741,427)
Accumulated other comprehensive loss (7,673,852) (3,944,110)
Total shareholders' equity 101,972,306 96,912,417
Total Liabilities and Shareholders' Equity 107,314,411 98,362,506
Class A Ordinary Share    
Shareholders' Equity:    
Ordinary share, value 122,966,148 104,486,710
Class B Ordinary Share    
Shareholders' Equity:    
Ordinary share, value $ 5,683,255 $ 4,231,055